Cargando…
Systemic treatment for unresectable hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is most commonly found in the context of liver cirrhosis and, in rare cases, in a healthy liver. Its prevalence has risen in recent years, particularly in Western nations, due to the increasing frequency of non-alcoholic fatty liver disease. Advanced HCC has a poor pro...
Autores principales: | Leowattana, Wattana, Leowattana, Tawithep, Leowattana, PathompThep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10037251/ https://www.ncbi.nlm.nih.gov/pubmed/36970588 http://dx.doi.org/10.3748/wjg.v29.i10.1551 |
Ejemplares similares
-
Systemic treatments for resectable carcinoma of the esophagus
por: Leowattana, Wattana, et al.
Publicado: (2023) -
Systemic treatment for metastatic colorectal cancer
por: Leowattana, Wattana, et al.
Publicado: (2023) -
Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023) -
Immunotherapy for advanced gastric cancer
por: Leowattana, Wattana, et al.
Publicado: (2023) -
Human-induced pluripotent stem cell-atrial-specific cardiomyocytes and atrial fibrillation
por: Leowattana, Wattana, et al.
Publicado: (2022)